清喉咽含片治疗急性咽炎临床研究.docVIP

清喉咽含片治疗急性咽炎临床研究.doc

此“医疗卫生”领域文档为创作者个人分享资料,不作为权威性指导和指引,仅供参考
  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
清喉咽含片治疗急性咽炎临床研究

清喉咽含片治疗急性咽炎临床研究   [摘要]研究评价了清喉咽含片相较于清喉咽合剂治疗急性咽炎(肺热阴虚证)的临床有效性和安全性。本试验共纳入144例受试者,随机分为试验组和对照组(各72例),试验组服用清喉咽含片,对照组服用清喉咽合剂,疗程5d,以咽痛或吞咽痛消失率、中医证候的综合疗效、中医证候积分、单项症状及体征的消失率等为有效性评价指标,试验过程中密切观察生命体征、实验室检查指标、不良事件安全性评价指标。FAS结果显示,咳嗽消失率、中医证候愈显率、咽黏膜、悬雍垂轻度充血水肿体征消失率均为试验组优于对照组(Plt;0.05),中医证候积分的变化值2组间差异有统计学意义(Plt;0.05);试验组有3例不良事件,对照组有6例不良事件,2组之间不良事件发生率差异无统计学意义,无严重实验室检查异常,无生命体征异常。综合以上研究,清喉咽含片治疗急性咽炎(肺热阴虚证)疗效优于清喉咽合剂,安全性良好。   [关键词]清喉咽含片;急性咽炎;咽痛;吞咽痛   Clinical stury on Qinghouyan lozenge in treatment of acute pharyngitis   YU Jiao-jiao1, XUAN Zhen-yu1*, RUAN Yan2, ZHANG Hui-yong3, SHI Ke-hua4, GUO Yu4   (1. Suzhou Youseen New Drug Ramp;D Co.Ltd., Suzhou 215123, China;   2. The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, China;   3. Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China;   4. Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai 200071, China)   [Abstruct]To evaluate the clinical efficacy and safety of Qinghouyan lozenge in the treatment of acute pharyngitis due to Lung-heat and Yin-deficiency, and compare with Qinghouyan oral Liquid. Totally 144 subjects were enrolled and randomly divided into two groups (72 in the test group and 72 in the control group). The participants in the test group were given Qinghouyan lozenge for 5 days, and those in the control group were given Qinghouyan oral Liquid for 5 days. The effectiveness evaluation indexes were pharyngalgia/odynophagia disappearance rate, overall efficacy of TCM syndromes, TCM syndrome scores, and single syndrome and sign disappearance rate. During the test, the safety was evaluated by vital sign, lab examination indexes and adverse events. The results for the full analysis set showed that the couth disappearance rate, the incidence rate of TCM syndromes, and the throat/uvula congestion disappearance rate of the test group were higher than that of the control group (Plt;0.05), with significant difference

文档评论(0)

bokegood + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档